SCHEMBL5653075

SCHEMBL5653075

CCOC(=O)CN1C2CC(=O)CC1CC(C(=O)OCC)C2.CS(=O)(=O)O

nearest known ligand 0.39

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
POLB P06746 3/20 0.37
GSK3A P49840 1/20 0.35
GSK3B P49841 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
LMNA P02545 2/20 0.34
ELANE P08246 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5121809 0.94 GSK3A (0.40) ALDH1A1SMN1; SMN2PSEN1PSEN2APH1B
SCHEMBL30028689 0.80 MEN1 (0.43) ALDH1A1SMN1; SMN2POLBGSK3AGSK3B
SCHEMBL5114769 0.78 MEN1 (0.40) ALDH1A1POLBGSK3AGSK3BMEN1
SCHEMBL3645840 0.78 GSK3A (0.45) ALDH1A1SMN1; SMN2POLBGSK3AGSK3B
SCHEMBL3689858 0.77 BRD4 (0.41) ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8912197 0.77 KMT2A (0.45) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL8912207 0.76 MEN1 (0.38) ALDH1A1POLBGSK3AGSK3BMEN1
Hydrochloric Acid SCHEMBL3693041 0.75 BRD4 (0.39) ALDH1A1SMN1; SMN2MEN1KMT2A
Ethyl Bromo Acetate SCHEMBL30029142 0.74 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL5652672 0.73 MEN1 (0.34) ALDH1A1SMN1; SMN2POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299260-A1 Method for Preparing Hexahydro-8-Hydroxy-2, 6-Methano-2H-Chinolizin-3 (4H) -One Esters CILAG LTD. (CH) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299260-A1 Method for Preparing Hexahydro-8-Hydroxy-2, 6-Methano-2H-Chinolizin-3 (4H) -One Esters CYP4Z1, HDHD5, HCAR2 ALDH1A1 541/4885SMN1; SMN2 4715/4885PSEN1 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.